Author

M. M. Bui

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Al-Ibraheemi· 1 shared A. C. Hirbe· 1 shared A. Chatzipli· 1 shared A. Feber· 1 shared A. Galor· 1 shared A. K. Miller· 1 shared A. Lopez· 1 shared A. M. Flanagan· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Al-Ibraheemi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cycles.

D. Miroshnychenko, T. Miti, P. Kumar, A. K. Miller, M. Laurie, N. Giraldo, M. M. Bui, P. M. Altrock, D. Basanta, A. Marusyk

The paper investigates how stromal factors indirectly enhance tumor chemoresistance by accelerating tumor recovery between chemotherapy cycles through paracrine signaling.

bioRxiv · Feb 7, 2023 · PreprintCancer Biology

Genomic patterns of malignant peripheral nerve sheath tumour (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA

I. Cortes-Ciriano, C. D. Steele, K. G. Piculell, A. Al-Ibraheemi, V. Eulo, M. M. Bui, A. Chatzipli, B. C. Dickson, D. C. Borcherding, A. Feber, A. Galor, J. Hart, K. B. Jones, J. T. Jordan, R. H. Kim, , D. T. Miller

This study identifies genomic patterns in MPNST evolution linked to clinical outcomes and shows these patterns are detectable in cell-free DNA.

bioRxiv · May 3, 2022 · PreprintCancer Biology

Proton export drives the Warburg Effect

S. Russell, L. Xu, Y. Kam, D. Abrahams, B. Ordway, A. Lopez, M. M. Bui, J. Johnson, T. Epstein, E. Ruiz, M. Lloyd, P. Swietach, D. Verduzco, J. Wojtkowiak, R. Gillies

This study shows that proton export drives the Warburg Effect by increasing intracellular alkalization, enhancing glycolytic flux, and promoting cancer aggressiveness.

bioRxiv · Sep 20, 2021 · PreprintCancer Biology

Targeting hypoxic habitats with hypoxia pro-drug evofosfamide in preclinical models of sarcoma

B. V. Jardim Perassi, W. Mu, S. Huang, M. R. Tomaszewski, J. Poleszczuk, M. A. Abdalah, M. M. Budzevich, W. Dominguez-Viqueira, D. R. Reed, M. M. Bui, J. O. Johnson, G. V. Martinez, R. J. Gillies

This paper develops deep-learning models to identify hypoxic tumor regions using MRI and histology, showing their effectiveness in predicting hypoxia and guiding TH-302 therapy response in sarcoma models.

bioRxiv · Oct 6, 2020 · PreprintCancer Biology